tisagenlecleucel
English
Etymology
From tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”).
Pronunciation
- IPA(key): /ˌtɪsəd͡ʒɛnləˈkluːsəl/, /ˌtɪsəd͡ʒɛnˈlɛkluːsəl/
Noun
tisagenlecleucel (uncountable)
- (pharmacology) An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies.
See also
- axicabtagene ciloleucel